7MM Type 1 Diabetes Market Drug Forecast and Market Analysis 2023-2024 & 2033: Value to Reach $9.91 Billion - Synergistic Rise of Pumps, CGMs, and Ultra-rapid-acting Insulins in T1D Management
17 janv. 2025 04h53 HE
|
Research and Markets
Dublin, Jan. 17, 2025 (GLOBE NEWSWIRE) -- The "Type 1 Diabetes: Seven-Market Drug Forecast and Market Analysis" report has been added to ResearchAndMarkets.com's offering.This report covers the 7MM...
Global Diabetes Epidemic: Unprecedented Economic Burden of $966 Billion in 2021 Underscores Urgency for Innovative Therapeutics and Diagnostics
18 sept. 2023 07h38 HE
|
Research and Markets
Dublin, Sept. 18, 2023 (GLOBE NEWSWIRE) -- The "Global Markets for Diabetes Therapeutics and Diagnostics" report has been added to ResearchAndMarkets.com's offering. The latest market analysis...
The Worldwide Diabetes Therapeutics Industry is Projected to Reach $3.3 Billion by 2030
12 oct. 2022 07h33 HE
|
Research and Markets
Dublin, Oct. 12, 2022 (GLOBE NEWSWIRE) -- The "Diabetes Therapeutics Market By Product: Global Opportunity Analysis and Industry Forecast, 2020-2030" report has been added to ...
Global Diabetes Pipeline Landscape Insights Report, 2021 - Featuring Emerging Drugs Tirzepatide, ORMD-0801, Ladarixin, Enavogliflozin, and DBPR-108
26 nov. 2021 07h53 HE
|
Research and Markets
Dublin, Nov. 26, 2021 (GLOBE NEWSWIRE) -- The "Diabetes - Pipeline Insight, 2021" clinical trials has been added to ResearchAndMarkets.com's offering. This report provides comprehensive insights...
Dementia with Diabetes Pipeline Insight Report, 2020 - Therapeutics Assessment by Product Type, Stage, Route of Administration, and Molecule Type
04 nov. 2020 07h03 HE
|
Research and Markets
Dublin, Nov. 04, 2020 (GLOBE NEWSWIRE) -- The "Dementia with Diabetes - Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. The "Dementia with Diabetes -...